Elanco Animal Health Incorporated (ELAN)
Company Info
US28414H1032
28414H103
Sep 20, 2018
Highlights
$4.79B
$0.68
14.19
4.82
$4.43B
$2.04B
$365.00M
$8.02 - $18.80
$13.86
6.09%
4.13
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Elanco Animal Health Incorporated, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Elanco Animal Health Incorporated (ELAN) returned -1.24% year-to-date (YTD) and -30.47% over the past 12 months.
ELAN
-1.24%
27.51%
-15.00%
-30.47%
-9.65%
N/A
^GSPC (Benchmark)
-3.77%
3.72%
-5.60%
8.55%
14.11%
10.45%
Monthly Returns
The table below presents the monthly returns of ELAN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -0.66% | -7.15% | -6.00% | -9.71% | 26.16% | -1.24% | |||||||
| 2024 | -1.07% | 7.80% | 2.45% | -19.16% | 34.35% | -18.38% | -9.63% | 18.63% | -5.04% | -13.96% | 4.51% | -8.33% | -18.72% |
| 2023 | 12.36% | -16.46% | -18.05% | 0.74% | -13.94% | 23.44% | 19.98% | 1.08% | -7.87% | -21.62% | 33.71% | 26.49% | 21.93% |
| 2022 | -8.25% | 9.10% | -8.17% | -2.99% | -6.36% | -17.17% | 3.21% | -25.32% | -17.98% | 6.29% | -2.43% | -5.05% | -56.94% |
| 2021 | -5.35% | 13.19% | -10.38% | 7.67% | 13.47% | -3.59% | 5.13% | -8.47% | -4.46% | 3.10% | -12.59% | -1.25% | -7.47% |
| 2020 | 4.92% | -11.33% | -18.28% | 10.36% | -13.35% | 0.19% | 10.16% | 22.98% | -3.89% | 11.03% | -1.35% | 0.26% | 4.14% |
| 2019 | -7.45% | 3.63% | 6.05% | -1.78% | -0.70% | 8.06% | -2.49% | -21.06% | 2.19% | 1.62% | 2.55% | 6.28% | -6.60% |
| 2018 | -3.08% | -12.64% | 9.61% | -5.63% | -12.42% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ELAN is 37, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Elanco Animal Health Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Elanco Animal Health Incorporated was 78.00%, occurring on May 30, 2023. The portfolio has not yet recovered.
The current Elanco Animal Health Incorporated drawdown is 67.43%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -78% | Aug 4, 2021 | 458 | May 30, 2023 | — | — | — |
| -53.91% | Sep 28, 2018 | 369 | Mar 18, 2020 | 340 | Jul 23, 2021 | 709 |
| -5.28% | Sep 21, 2018 | 1 | Sep 21, 2018 | 4 | Sep 27, 2018 | 5 |
| -1.89% | Jul 26, 2021 | 1 | Jul 26, 2021 | 2 | Jul 28, 2021 | 3 |
| -0.46% | Jul 29, 2021 | 2 | Jul 30, 2021 | 2 | Aug 3, 2021 | 4 |
Volatility
Volatility Chart
The current Elanco Animal Health Incorporated volatility is 27.09%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Elanco Animal Health Incorporated over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Elanco Animal Health Incorporated, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -5.8%.
Valuation
The Valuation section provides an overview of how Elanco Animal Health Incorporated is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ELAN, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ELAN has a P/E ratio of 14.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ELAN compared to other companies in the Drug Manufacturers - Specialty & Generic industry. ELAN currently has a PEG ratio of 4.8. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ELAN relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ELAN has a P/S ratio of 1.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ELAN in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ELAN has a P/B value of 0.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |